
WUHAN HVSEN BIOTECHNOLOGY CO.,LTD. — Investor Relations & Filings
Wuhan Hvsen Biotechnology Co., Ltd. specializes in the research, development, manufacturing, and distribution of veterinary pharmaceuticals and animal health solutions. The company's product portfolio includes a wide range of veterinary drugs such as antibiotics, antiparasitics, and anti-inflammatory agents, alongside vaccines, feed additives, and specialized disinfectants. Hvsen Biotechnology focuses on enhancing livestock productivity and animal welfare, primarily serving the swine, poultry, and cattle industries. Operating with advanced GMP-certified production facilities, the company emphasizes technological innovation and quality control to meet international standards. Its business model integrates scientific research with industrial application, providing comprehensive health management programs for large-scale farming operations and global distribution networks.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于收到深圳证券交易所终止对公司申请向特定对象发行股票审核决定的公告 | 2026-05-22 | Chinese | |
| 关于完成注册资本、经营范围变更登记并换发营业执照的公告 | 2026-05-13 | Chinese | |
| 国浩律师(深圳)事务所关于武汉回盛生物科技股份有限公司2025年度股东会法律意见书 | 2026-05-08 | Chinese | |
| 2025年年度股东会决议公告 | 2026-05-08 | Chinese | |
| 2025年度会计师事务所履职情况评估报告 | 2026-04-16 | Chinese | |
| 关于举办2025年度网上业绩说明会的公告 | 2026-04-16 | Chinese |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46788420 | 关于收到深圳证券交易所终止对公司申请向特定对象发行股票审核决定的公告 | 2026-05-22 | Chinese | ||
| 45481108 | 关于完成注册资本、经营范围变更登记并换发营业执照的公告 | 2026-05-13 | Chinese | ||
| 44261882 | 国浩律师(深圳)事务所关于武汉回盛生物科技股份有限公司2025年度股东会法律意见书 | 2026-05-08 | Chinese | ||
| 44261903 | 2025年年度股东会决议公告 | 2026-05-08 | Chinese | ||
| 39130229 | 2025年度会计师事务所履职情况评估报告 | 2026-04-16 | Chinese | ||
| 39130227 | 关于举办2025年度网上业绩说明会的公告 | 2026-04-16 | Chinese | ||
| 39130226 | 2025年度内部控制审计报告 | 2026-04-16 | Chinese | ||
| 39130224 | 董事、高级管理人员薪酬管理办法(2026年4月) | 2026-04-16 | Chinese | ||
| 39130221 | 关于召开2025年年度股东会的通知 | 2026-04-16 | Chinese | ||
| 39130220 | 董事会关于2025年度募集资金存放、管理与使用情况的专项报告 | 2026-04-16 | Chinese | ||
| 39130219 | 关于武汉回盛生物科技股份有限公司募集资金年度存放、管理与使用情况的鉴证报告 | 2026-04-16 | Chinese | ||
| 39130215 | 关于为全资子公司增加担保额度的的公告 | 2026-04-16 | Chinese | ||
| 39130213 | 关于2025年度利润分配方案及2026年中期分红规划的公告 | 2026-04-16 | Chinese | ||
| 39130211 | 武汉回盛生物科技股份有限公司2025年度非经营性资金占用及其他关联资金往来情况汇总表 | 2026-04-16 | Chinese | ||
| 39130210 | 董事会关于独立董事独立性情况的专项意见 | 2026-04-16 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
WUHAN HVSEN BIOTECHNOLOGY CO.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55839/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55839 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55839 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55839 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55839}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for WUHAN HVSEN BIOTECHNOLOGY CO.,LTD. (id: 55839)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.